- Home
- MX vs PLRX Comparison
MX vs PLRX Comparison
Compare MX & PLRX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- MX
- PLRX
- Stock Information
- Founded
- MX 2003
- PLRX 2015
- Country
- MX South Korea
- PLRX United States
- Employees
- MX N/A
- PLRX N/A
- Industry
- MX Semiconductors
- PLRX Biotechnology: Pharmaceutical Preparations
- Sector
- MX Technology
- PLRX Health Care
- Exchange
- MX Nasdaq
- PLRX Nasdaq
- Market Cap
- MX 112.8M
- PLRX 93.3M
- IPO Year
- MX N/A
- PLRX 2020
- Fundamental
- Price
- MX $2.29
- PLRX $1.61
- Analyst Decision
- MX Strong Buy
- PLRX Hold
- Analyst Count
- MX 2
- PLRX 11
- Target Price
- MX $5.75
- PLRX $3.79
- AVG Volume (30 Days)
- MX 401.8K
- PLRX 973.1K
- Earning Date
- MX 11-03-2025
- PLRX 11-06-2025
- Dividend Yield
- MX N/A
- PLRX N/A
- EPS Growth
- MX N/A
- PLRX N/A
- EPS
- MX N/A
- PLRX N/A
- Revenue
- MX $234,243,000.00
- PLRX N/A
- Revenue This Year
- MX N/A
- PLRX N/A
- Revenue Next Year
- MX $3.88
- PLRX N/A
- P/E Ratio
- MX N/A
- PLRX N/A
- Revenue Growth
- MX 16.02
- PLRX N/A
- 52 Week Low
- MX $2.21
- PLRX $1.10
- 52 Week High
- MX $5.16
- PLRX $15.88
- Technical
- Relative Strength Index (RSI)
- MX 20.97
- PLRX 47.40
- Support Level
- MX $2.95
- PLRX $1.61
- Resistance Level
- MX $3.23
- PLRX $1.72
- Average True Range (ATR)
- MX 0.15
- PLRX 0.13
- MACD
- MX -0.08
- PLRX -0.02
- Stochastic Oscillator
- MX 4.42
- PLRX 29.00
About MX Magnachip Semiconductor Corporation
MagnaChip Semiconductor Corp designs and manufactures analog and mixed-signal semiconductor platform solutions for communications, Internet of Things applications, consumer, industrial and automotive applications. The company's product portfolio consists of large display solutions, mobile display solutions, sensor solutions, LED solutions, mobile solutions, and power conversions. The company operates in two segments namely, Transitional Fab 3 foundry services and Standard products business. The company operates in Korea, Asia Pacific (other than Korea), United States and Europe.
About PLRX Pliant Therapeutics Inc.
Pliant Therapeutics Inc is a clinical-stage biopharmaceutical company focused on discovering and developing novel therapies for the treatment of fibrosis and related diseases. Its primary product candidate is bexotegrast (PLN-74809), an oral, small molecule, that the company is developing for the treatment of idiopathic pulmonary fibrosis, or IPF, and primary sclerosing cholangitis.